Predicting the metastatic potential in breast cancer patients in Bangladesh

被引：0
|
作者：
Akter, Salima
Saiedullah, Muhammad
Bhowmik, Mousumi
Akhter, Hajara
Ansary, Shahina
Akhtar, Waheed
Rahman, Sufi Hannan Zulfiqur
Choi, Tae Gyu
Kim, Sung Soo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2099
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2099
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Potential predictive factors for response to weekly paclitaxel treatment in patients with metastatic breast cancer
    Sezgin, C
    Karabulut, B
    Uslu, R
    Sanli, UA
    Goksel, G
    Zekioglu, O
    Ozdemir, N
    Goker, E
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (01) : 96 - 103
  • [42] MOLECULAR METHODS FOR PREDICTING THE METASTATIC POTENTIAL OF PROSTATE-CANCER
    SCHALKEN, JA
    CANCER SURVEYS, 1991, 11 : 43 - 54
  • [43] Stratification and therapeutic potential of PML in metastatic breast cancer
    Natalia Martín-Martín
    Marco Piva
    Jelena Urosevic
    Paula Aldaz
    James D. Sutherland
    Sonia Fernández-Ruiz
    Leire Arreal
    Verónica Torrano
    Ana R. Cortazar
    Evarist Planet
    Marc Guiu
    Nina Radosevic-Robin
    Stephane Garcia
    Iratxe Macías
    Fernando Salvador
    Giacomo Domenici
    Oscar M. Rueda
    Amaia Zabala-Letona
    Amaia Arruabarrena-Aristorena
    Patricia Zúñiga-García
    Alfredo Caro-Maldonado
    Lorea Valcárcel-Jiménez
    Pilar Sánchez-Mosquera
    Marta Varela-Rey
    Maria Luz Martínez-Chantar
    Juan Anguita
    Yasir H. Ibrahim
    Maurizio Scaltriti
    Charles H. Lawrie
    Ana M. Aransay
    Juan L. Iovanna
    Jose Baselga
    Carlos Caldas
    Rosa Barrio
    Violeta Serra
    Maria dM Vivanco
    Ander Matheu
    Roger R. Gomis
    Arkaitz Carracedo
    Nature Communications, 7
  • [44] Genome organization and metastatic potential in breast cancer.
    Gaillard, M.
    Cutler, J.
    Luperchio, T.
    Brener, B.
    Wu, P.
    Taylor, J.
    Writz, D.
    Reddy, K.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [45] Leptin increases the metastatic potential of breast cancer cells
    Misrha, Arneet
    Blackburn, Anneke C.
    Parish, Christopher R.
    Wong, Ma-li
    Licinio, Julio
    CANCER RESEARCH, 2013, 73
  • [46] Therapeutic potential of PARP inhibitors for metastatic breast cancer
    Irshad, Sheeba
    Ashworth, Alan
    Tutt, Andrew
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (08) : 1243 - 1251
  • [47] A potential therapeutic target for early metastatic breast cancer
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (05) : 372 - 372
  • [48] An engineered niche delineates metastatic potential of breast cancer
    Orbach, Sophia M.
    Devaull, Christian Y.
    Bealer, Elizabeth J.
    Ross, Brian C.
    Jeruss, Jacqueline S.
    Shea, Lonnie D.
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2024, 9 (01)
  • [49] Stratification and therapeutic potential of PML in metastatic breast cancer
    Martin-Martin, Natalia
    Piva, Marco
    Urosevic, Jelena
    Aldaz, Paula
    Sutherland, James D.
    Fernandez-Ruiz, Sonia
    Arreal, Leire
    Torrano, Veronica
    Cortazar, Ana R.
    Planet, Evarist
    Guiu, Marc
    Radosevic-Robin, Nina
    Garcia, Stephane
    Macias, Iratxe
    Salvador, Fernando
    Domenici, Giacomo
    Rueda, Oscar M.
    Zabala-Letona, Amaia
    Arruabarrena-Aristorena, Amaia
    Zuniga-Garcia, Patricia
    Caro-Maldonado, Alfredo
    Valcarcel-Jimenez, Lorea
    Sanchez-Mosquera, Pilar
    Varela-Rey, Marta
    Martinez-Chantar, Maria Luz
    Anguita, Juan
    Ibrahim, Yasir H.
    Scaltriti, Maurizio
    Lawrie, Charles H.
    Aransay, Ana M.
    Iovanna, Juan L.
    Baselga, Jose
    Caldas, Carlos
    Barrio, Rosa
    Serra, Violeta
    Vivanco, Maria dM
    Matheu, Ander
    Gomis, Roger R.
    Carracedo, Arkaitz
    NATURE COMMUNICATIONS, 2016, 7
  • [50] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo, D. J. A.
    van Kampen, R. J. W.
    Voogd, A. C.
    Dercksen, M. W.
    van den Berkmortel, F.
    Smilde, T. J.
    van de Wouw, A. J.
    Peters, F. P. J.
    van Riel, J. M. G. H.
    Peters, N. A. J. B.
    de Boer, M.
    Peer, P. G. M.
    Tjan-Heijnen, V. C. G.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1445 - 1451
12345